|
|
|
貝萊德世界健康科學基金A2
(美元)
| 幣別 |
淨值 |
漲跌 |
漲跌比例 |
日期 |
| 美元 |
50.52 |
0.22 |
0.44% |
2019/12/12 |
|
|
| 2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
| 23.49% |
1.59% |
5.46% |
16.89% |
43.09% |
24.40% |
4.56% |
-8.02% |
21.78% |
4.98% |
| 貝萊德世界健康科學基金A2(美元)
基金資料
|
|
●以盡量提高總回報為目標。基金在全球將總資產至少70%投資於從事保健、製藥、 醫學科技及生物科技供應及開發業務公司之股權證券。
●投資經驗豐富的研究團隊。健康醫療研究團隊成立超過半世紀，擁有產業豐富的投資經驗與優異的投資績效。
●掌握健康醫療產業長期投資利機點--全球人口老化、 重大醫學科技突破，以及中國、印度、東歐等快速成長新興市場生活水準提高。
●同時囊括醫療產業中生技、製藥、醫療保險服務與設備4大領域，兼顧防禦與成長。
|
| 日期 |
淨值 |
漲跌比例 |
日期 |
淨值 |
漲跌比例 |
| 2019/12/12 |
50.52 |
0.44% |
2019/11/28 |
50.25 |
0.24% |
| 2019/12/11 |
50.30 |
0.38% |
2019/11/27 |
50.13 |
0.20% |
| 2019/12/10 |
50.11 |
-0.32% |
2019/11/26 |
50.03 |
0.34% |
| 2019/12/09 |
50.27 |
-0.30% |
2019/11/25 |
49.86 |
0.79% |
| 2019/12/06 |
50.42 |
0.78% |
2019/11/22 |
49.47 |
0.59% |
| 2019/12/05 |
50.03 |
0.06% |
2019/11/21 |
49.18 |
-0.49% |
| 2019/12/04 |
50.00 |
0.97% |
2019/11/20 |
49.42 |
0.47% |
| 2019/12/03 |
49.52 |
-0.88% |
2019/11/19 |
49.19 |
1.51% |
| 2019/12/02 |
49.96 |
-0.36% |
2019/11/15 |
48.46 |
0.50% |
| 2019/11/29 |
50.14 |
-0.22% |
2019/11/14 |
48.22 |
0.10% |
基金績效 (可點按欄位名稱排序)
| 名稱 |
一日 |
一週 |
一個月 |
三個月 |
六個月 |
一年 |
今年以來 |
|
0.44% |
0.98% |
4.92% |
10.35% |
12.74% |
14.51% |
21.73% |
| NBI生技指數 |
0.04% |
0.28% |
8.85% |
15.40% |
15.60% |
15.80% |
24.20% |
| 費城藥物指數 |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| AMEX生技指數 |
0.65% |
0.30% |
10.74% |
14.91% |
11.67% |
13.21% |
20.63% |
| MSCI 全球醫療保健指數 (price) |
0.00% |
0.33% |
4.46% |
9.94% |
10.75% |
11.78% |
17.97% |
| MSCI 製藥指數 (price) |
0.00% |
1.11% |
4.49% |
9.38% |
9.06% |
7.81% |
14.24% |
| MSCI 生物科技指數 (price) |
0.00% |
-0.16% |
4.84% |
17.09% |
17.08% |
12.79% |
15.25% |
|
0.46% |
-0.04% |
3.72% |
9.32% |
9.36% |
11.81% |
17.81% |
|
0.46% |
-0.06% |
3.63% |
9.05% |
8.81% |
10.70% |
16.71% |
|
-0.88% |
-0.85% |
7.29% |
15.21% |
17.35% |
16.53% |
29.18% |
|
-0.38% |
-0.79% |
7.51% |
9.88% |
9.39% |
7.35% |
18.13% |
|
0.13% |
0.75% |
3.89% |
9.05% |
14.67% |
16.95% |
25.10% |
|
0.45% |
0.29% |
5.14% |
10.96% |
11.13% |
12.25% |
20.33% |
|
0.06% |
-0.73% |
3.11% |
3.90% |
3.37% |
7.26% |
14.35% |
|
0.04% |
-0.75% |
2.88% |
6.29% |
6.48% |
8.63% |
15.17% |
|
1.84% |
3.08% |
3.31% |
16.12% |
35.88% |
44.00% |
45.04% |
|
0.24% |
0.61% |
3.80% |
7.05% |
11.85% |
16.87% |
24.41% |
|
1.81% |
0.47% |
10.89% |
7.98% |
8.45% |
10.93% |
21.15% |
|
1.79% |
0.44% |
10.79% |
7.63% |
7.73% |
9.47% |
19.77% |
|
-0.10% |
-0.09% |
6.41% |
11.71% |
12.88% |
N/A% |
25.35% |
|
0.80% |
1.64% |
6.68% |
12.21% |
11.85% |
16.60% |
24.05% |
|
0.81% |
1.64% |
6.61% |
11.93% |
11.29% |
15.44% |
22.87% |
|
0.79% |
1.59% |
6.50% |
11.43% |
10.14% |
12.82% |
20.31% |
|
0.78% |
1.60% |
6.54% |
11.61% |
10.54% |
13.65% |
21.16% |
|
0.79% |
1.64% |
6.73% |
12.39% |
12.22% |
17.44% |
24.92% |
|
-0.22% |
-0.28% |
4.65% |
9.01% |
7.01% |
9.54% |
17.93% |
|
-0.43% |
0.35% |
9.19% |
15.60% |
14.29% |
14.20% |
26.06% |
|
-0.72% |
0.20% |
8.31% |
15.06% |
17.93% |
20.55% |
33.61% |
|
-0.42% |
0.40% |
9.37% |
16.42% |
15.92% |
18.00% |
29.99% |
|
0.35% |
0.09% |
2.99% |
6.93% |
6.38% |
7.47% |
15.86% |
|
0.07% |
-0.07% |
2.16% |
6.43% |
9.78% |
13.36% |
22.73% |
|
0.37% |
0.14% |
3.17% |
7.68% |
7.92% |
10.97% |
19.40% |
|
-0.49% |
-0.76% |
8.42% |
18.04% |
18.24% |
17.50% |
28.13% |
|
0.07% |
0.06% |
5.47% |
11.77% |
13.37% |
17.83% |
25.91% |
|
0.73% |
1.48% |
8.50% |
12.96% |
17.06% |
17.06% |
26.21% |
|
1.00% |
2.02% |
9.16% |
14.73% |
17.73% |
18.42% |
26.96% |
| 基金平均績效 |
0.35% |
0.50% |
6.06% |
10.96% |
12.39% |
14.76% |
23.34% |
* 基金報酬率包含配息
(若未註明"*"，則基金報酬率不包含配息，對於有配息之基金，將造成總報酬率數值低估。)
本資訊僅供參考，實際數據以官方公佈資料為準。 本站自當盡力為使用者提供正確的意見及消息，但如有錯漏或疏忽，本站恕不負任何法律責任。
|
